Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $118.37
  • Support level
    $114.73
  • Resistance level
    N/A
  • Beta
    0.4
  • RSI (14-day)
    61.5
  • GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
  • With a 60.0 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
  • Volatility is forecast to fall over the next month.
  • Price broke above prior resistance level - a short-term bullish signal.

52-week range
52-week low 52-week high Price as % of range
$73.78 $120.47 96.4%

Moving averages
200 day 50 day 20 day 10 day
$103.27 $111.97 $114.69 $116.50

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    6.3%
  • In the next month
    13.4%
  • In the next year
    52.9%

Volatility estimates (annualized standard deviations)
Period Value
Historical (5 year) 23.4%
Last month 23.2%
Current estimate 23.2%
Next month forecast 23.7%